RediNews
ETFs Holding BSTC »    BSTC Historical Stock Prices »
BSTC News Video: Thu, May 23, 2019, 1:35 PM — Thursday 5/23 Insider Buying Report: EOLS, OTEL


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
BioSpecifics Technologies is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. As of Dec 31 2017, Co. had a development and license agreement with Endo Global Ventures, for injectable collagenase for marketed indications and indications in development. Injectable collagenase clostridium histolyticum is marketed as XIAFLEX® or Xiapex® in Europe. The two marketed indications involving Co.'s injectable collagenase are Dupuytren's contracture and Peyronie's disease. Co. is evaluating its options for development of additional indications using collagenase. Self directed investors in Biospecifics Technologies Corp. will be interested in keeping up with all Biospecifics Technologies Corp. news they can find, both BSTC news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on BSTC. At RediNews, we simplify this task by presenting both BSTC news releases originating from Biospecifics Technologies Corp. itself, and BSTC news from a variety of media outlets. Visitors can browse this news online and through our BSTC RSS news feed.

BSTC News

BSTC News — Articles, Videos, & Press Releases

Biospecifics Technologies Enters Oversold Territory (BSTC)
2 hours, 53 minutes ago — Dividend Channel
ImmunoGen Plunges as FDA Recommends New Study for Lead Drug
Thursday, May 16, 2019, 2:35 PM — Zacks
Catalyst (CPRX) Q1 Loss Narrows, Firdapse Off to a Good Start
Tuesday, May 14, 2019, 12:36 PM — Zacks
Zoetis (ZTS) Earnings Beat Estimates in Q1, Revenues Miss
Thursday, May 2, 2019, 12:34 PM — Zacks
What's in Store for BioSpecifics (BSTC) This Earnings Season?
Tuesday, April 30, 2019, 6:02 AM — Zacks
Achaogen (AKAO) Files for Bankruptcy, Shares Plunge 65%
Tuesday, April 16, 2019, 5:17 PM — Zacks
Zogenix Gets Refusal to File Letter From FDA for Seizure Drug
Tuesday, April 9, 2019, 8:29 AM — Zacks
4 Top Stocks to Buy for Superb Earnings Growth
Friday, March 22, 2019, 6:01 AM — Zacks
What's in Store for BioSpecifics (BSTC) This Earnings Season?
Tuesday, March 5, 2019, 3:36 PM — Zacks
Bullish Two Hundred Day Moving Average Cross - BSTC
Tuesday, June 5, 2018, 5:02 PM — Market News Video
BSTC is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

ASPX News
EBIO News
NRCIA News
RARE News
RCPT News
FMI News
RDNT News
TRIV News
CLDN News
GLYC News

The best thing about dynamic market content like our RediNews RSS feeds is it constantly changes, giving your users a reason to keep coming back. Even if you have never worked with XML stock data before, you'll find our RSS feeds simple to integrate because they follow the Really Simple Syndication (RSS) standard. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . Seldom is free web content of such high quality and usefulness as our feeds, so give them a try and let RediNews be your financial content provider of choice for news headlines either within your existing web page content or create a new stock content section to add to your current web site offerings. Remember, our RSS feeds are absolutely free, so unlike some other types of content requiring a costly stock data content license, we charge nothing for this dynamic web content.

BSTC News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.